Notwithstanding Article 3(a) and without prejudice to Articles 2 and 11a, Member States may authorise the administering to farm animals of veterinary medicinal products containing oestradiol 17β or its ester-like derivatives for:
the treatment of foetus maceration or mummification in cattle, or
the treatment of pyometra in cattle,
in accordance with Directive 2001/82/EC.
Notwithstanding Article 3(a) and without prejudice to Article 2, Member States may authorise the administering to farm animals of veterinary medicinal products containing oestradiol 17β or its ester-like derivatives for oestrus induction in cattle, horses, sheep or goats until 14 October 2006, in accordance with Directive 2001/82/EC.
The treatment must be carried out by the veterinarian himself or herself on farm animals which have been clearly identified. This treatment must be registered by the veterinarian responsible. The latter must record at least the following details in a register, which may be that provided for in Directive 2001/82/EC:
the type of product administered,
the nature of the treatment,
the date of treatment,
the identity of the animals treated,
the date of expiry of the withdrawal period.
The register must be made available to the competent authority at its request.
Stockfarmers shall be prohibited from holding on their farms veterinary medicinal products containing oestradiol 17β or its ester-like derivatives.